Drug Shortage Report for TEVA-ALENDRONATE/CHOLECALCIFEROL
Report ID | 23146 |
Drug Identification Number | 02403641 |
Brand name | TEVA-ALENDRONATE/CHOLECALCIFEROL |
Common or Proper name | ALENDRONATE VIT D |
Company Name | TEVA CANADA LIMITED |
Market Status | DORMANT |
Active Ingredient(s) | ALENDRONIC ACID VITAMIN D3 |
Strength(s) | 70MG 5600UNIT |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 4 |
ATC code | M05BB |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2017-11-20 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2018-12-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2018-10-11 | French | Compare |
v6 | 2018-10-11 | English | Compare |
v5 | 2018-01-03 | French | Compare |
v4 | 2018-01-03 | English | Compare |
v3 | 2017-11-21 | English | Compare |
v2 | 2017-09-22 | French | Compare |
v1 | 2017-09-22 | English | Compare |
Showing 1 to 7 of 7